Snap-8 Supplier

Selecting a Verified Snap-8 Supplier for Analytical Research

A reliable Snap-8 supplier provides research laboratories with fully characterized, high-purity Acetyl Octapeptide-3 accompanied by lot-specific documentation, including RP-HPLC purity profiles, mass spectrometry confirmation, and endotoxin analysis. PX1 Research manufactures research-grade SNAP-8 in USA-based, GMP-compliant facilities to ensure strict batch-to-batch consistency for cellular and biochemical assays.

When sourcing peptides for preclinical investigation, quantitative certainty is essential. Laboratories conducting comparative experiments on vesicle fusion, signal transduction, or membrane dynamics require reference materials free from counter-ion imbalances, residual trifluoroacetic acid (TFA) excess, or truncated peptide impurities. Selecting a vendor that provides transparent analytical access ensures that observed experimental outcomes stem directly from the target molecule rather than background variables.

Chemical Structure and Molecular Properties of SNAP-8

SNAP-8, scientifically designated as Acetyl Octapeptide-3 (or Acetyl Glutamyl-Glutamyl-Methionyl-Glutaminyl-Arginyl-Arginyl-Alanyl-Aspartamide), is an elongated synthetic analog of the hexapeptide Argireline. Composed of eight amino acid residues with an N-terminal acetylation and C-terminal amidation, the peptide features a molecular formula of C41H70N16O16S and a molecular weight of approximately 1075.16 g/mol.

The molecular design of SNAP-8 is patterned after the N-terminal end of the SNAP-25 protein (Synaptosomal-Associated Protein 25). By extending the peptide sequence beyond six amino acids, researchers can evaluate how sequence length influences steric interactions and binding affinity within molecular models. PX1 Research maintains high-purity synthesis of this sequence for integration into our comprehensive catalog of research peptides.

Mechanism of Action: In Vitro SNARE Complex Interruption

The SNARE (Soluble N-ethylmaleimide-sensitive factor Attachment Protein Receptor) complex is a ternary protein bundle comprised of SNAP-25, synaptobrevin, and syntaxin. This complex plays a central role in mediating exocytosis by facilitating membrane fusion between synaptic vesicles and the plasma membrane. In preclinical neuronal cell models, neurotransmitter release depends directly on the structural integrity of this three-protein assembly.

Preclinical studies suggest that SNAP-8 acts as a competitive inhibitor of SNAP-25. By mimicking the binding domain of SNAP-25, the octapeptide competes for position within the SNARE ternary complex. In vitro data indicate that when SNAP-8 destabilizes or destabilizes the assembly of the SNARE complex, the calcium-dependent release of neurotransmitters (such as catecholamines) from cultured cell lines is attenuated. Researchers frequently measure vesicle fusion rates using fluorescent dye release or electrochemical detection to quantify this inhibition.

Preclinical Findings: Comparing SNAP-8 and Neuromuscular Signal Peptides

Comparative in vitro evaluation demonstrates that sequence modifications significantly influence functional potency. In cell culture models measuring catecholamine secretion, SNAP-8 has demonstrated an enhanced capacity to disrupt SNARE complex formation relative to its hexapeptide predecessor, Argireline (Acetyl Hexapeptide-8). Furthermore, researchers investigating complementary signaling pathways often evaluate Leuphasyl (Pentapeptide-18) alongside SNAP-8 to examine dual-mechanism approaches—where Leuphasyl targets enkephalin receptors to modulate neuronal excitability while SNAP-8 directly interrupts the downstream SNARE assembly.

In cell viability and kinetic assays, octapeptides display distinct structural stabilities compared to shorter peptides. Researchers evaluating membrane permeability, enzymatic degradation rates, or competitive binding kinetics use controlled concentrations of SNAP-8 to establish baseline parameters for synthetic SNARE-mimetics across varying buffer formulations.

Supplier Purity Standards: RP-HPLC and ESI-MS Validation

Evaluating a Snap-8 supplier requires scrutinizing the analytical metrics provided in the Certificate of Analysis (COA). Standard peptide synthesis can leave residual side-products, including deletions, truncations, or persistent protecting groups. Reliable research suppliers mitigate these issues through rigorous multi-step purification protocols.

PX1 Research subjects every batch of research peptides to rigorous verification standards, including:

• Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC): Establishes chemical purity, guaranteeing that target peptide peak area exceeds 98.0% relative to total integration area. • Electrospray Ionization Mass Spectrometry (ESI-MS): Verifies exact molecular mass, confirming correct amino acid sequence synthesis and absence of high-mass adducts. • Bacterial Endotoxin Testing: Utilizes Limulus Amebocyte Lysate (LAL) assays to confirm endotoxin levels remain strictly controlled for sensitive cell culture experiments. • Residual Solvent & TFA Quantification: Ensures counter-ion balances do not interfere with cell viability or enzyme activity in downstream assays.

Review our complete peptide purity testing standards to understand how analytical verification protects experimental consistency.

Laboratory Reconstitution and Solution Preparation Protocols

SNAP-8 is supplied as a lyophilized (freeze-dried) powder to maximize chemical stability during transport and storage. Proper laboratory preparation requires standard aseptic technique under a certified laminar flow hood to maintain compound integrity.

For reconstituted in vitro assays, researchers typically dissolve SNAP-8 in bacteriostatic water or sterile phosphate-buffered saline (PBS, pH 7.4). Due to the hydrophilic nature of its basic arginyl and acidic glutamyl side chains, Acetyl Octapeptide-3 demonstrates rapid solubility in aqueous media. If high-concentration stock solutions are required, gentle vortexing or short sonication may be applied. Avoid aggressive agitation to prevent mechanical shearing or structural aggregation of the peptide chain.

Storage Parameters and Degradation Considerations

Lyophilized SNAP-8 should be stored in a freezer at -20°C or -80°C away from light and moisture to maintain stability over extended periods. Upon arrival, vials should be allowed to equilibrate to room temperature inside a desiccator before opening to prevent condensation of atmospheric moisture onto the dry cake.

Once reconstituted into aqueous solution, stock aliquots should be divided into single-use experimental volumes to avoid repeated freeze-thaw cycles. Freeze-thaw stress accelerates peptide hydrolysis and physical aggregation. Reconstituted solutions held at 4°C are typically stable for short-term handling (up to 7–14 days depending on buffer conditions), while frozen aliquots kept at -80°C maintain structural integrity for longer-term experimental series.

Sourcing USA-Manufactured SNAP-8 from PX1 Research

PX1 Research serves as a premier USA-based supplier of analytical-grade peptides for academic institutions, biotechnology firms, and contract research organizations (CROs). All peptides are synthesized in domestic, GMP-compliant facilities and shipped directly from our primary distribution hubs in California and Arizona.

Orders placed before daily cutoffs feature same-day dispatch (Monday through Friday), minimizing thermal exposure during transit. Laboratories requiring custom batch sizes, specialized packaging, or volume procurement for extended trial phases can access our dedicated wholesale supplier portal or explore our central research hub for technical support and analytical documentation.